LOGIN  |  REGISTER
Cue Biopharma
Astria Therapeutics

DBV Technologies: Monthly information regarding the total number of voting rights and total number of shares of the Company as of June 30, 2023

July 19, 2023 | Last Trade: US$10.83 0.16 -1.46

Monthly information regarding the total number of voting rights and total number of shares of the Company as of June 30, 2023

(Article 223-16 of the General Regulations of the Autorité des Marchés Financiers)

Market : NYSE Euronext Paris

ISIN Code: FR 0010417345

 

Date

 
Total number of shares Total number of voting rights
06/30/202396,250,954 

Total gross of voting rights: 96,250,954

 
 

Total net* of voting rights: 96,100,982

 

* Net total = total number of voting rights attached to shares – shares without voting rights = 96,250,954 –149,972= 96,100,982

Stock Quote

Featured Stock

Compass Therapeutics

Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...

CLICK TO LEARN MORE

Featured Stock

Recursion

Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....

CLICK TO LEARN MORE

End of content

No more pages to load

Next page